Patients
Physicians
Clinical Studies
Stories
About
Team
News
Careers
Contact
Archive
Ancora Heart Receives IDE Approval for CorCinch-HF Pivotal Study of the AccuCinch® Ventricular Restoration System
June 30, 2020
By
ancorastaging
Ancora Heart Enrolls First Patient in The CORCINCH-HF Study
January 28, 2021
By
ancorastaging
Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced enrollment of the first patient in the CORCINCH-HF pivotal trial.
Ancora Heart Secures $80 Million in Financing
July 20, 2021
By
ancorastaging
Ancora Heart Appoints Mark Miles as Chief Commercial Officer
June 23, 2022
By
Matt Merkert
Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System
July 12, 2022
By
Matt Merkert
ANCORA HEART’S ACCUCINCH SYSTEM DEMONSTRATES SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, CARDIAC STRUCTURE AND FUNCTION IN HEART FAILURE PATIENTS
March 23, 2023
By
Matt Merkert
Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
April 19, 2023
By
Matt Merkert
To Learn More
GET IN TOUCH